Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion

The introduction of targeted treatments and more recently immune checkpoint inhibitors (ICI) to the treatment of metastatic non-small cell lung cancer (NSCLC) has dramatically changed the prognosis of selected patients. For patients with oncogene-addicted metastatic NSCLC harbouring an epidermal gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghoff, Anna S., Bellosillo, Beatriz, Caux, Christophe, de Langen, Adrianus, Mazieres, Julien, Normanno, Nicola, Preusser, Matthias, Provencio, Mariano, Rojo, Federico, Wolf, Jurgen, Zielinski, Christoph C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586213/
https://www.ncbi.nlm.nih.gov/pubmed/31297240
http://dx.doi.org/10.1136/esmoopen-2019-000498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586213/
https://www.ncbi.nlm.nih.gov/pubmed/31297240
http://dx.doi.org/10.1136/esmoopen-2019-000498

Ejemplares similares